Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Silver North Intersects 1.83 metres True Width of 1,088 g/t Silver, 3.90 g/t Gold (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum ProMIS Neurosciences Inc PMN

Healthcare Biotechnology
ProMIS Neurosciences Inc. is a clinical-stage biotechnology company. It is focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA). Its proprietary target discovery engine applies a thermodynamic, computational... see more

NDAQ:PMN - Post Discussion

ProMIS Neurosciences Inc > Almost
View:
Post by BottomBroker on Jun 14, 2023 4:17pm

Almost

Almost made it back to $7 on the TSX . But, as per usual, a late-day trade puts an end to that. 

Funny, that.
Comment by Speyeder999 on Jun 14, 2023 7:46pm
Smoke and mirrors if you ask me. Gave up on seeing an increase in share price when I saw the FDA nod had zero effect. Fully expecting the share price to dwindle down to $6.00 in time for the (surprise) financing, It's this way because someone wants it this way. 
Comment by FarmerBetty on Jun 14, 2023 8:12pm
Was gaining steam at the end of April, 27,28 trading value $126,449 and $ 145,382, today $ 5,554. Couldn't be more clear the insiders put a stop to the momentum at the end of April, 
ProMIS Neurosciences Inc